🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and safety of recombi...
Status
Unknown
Location
307 Hospital of PLA
Start Date
2015-05
Trial ID
NCT02455596
Treatments Being Tested
The goal of the Phase I part of this clinical research study is to find the...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2013-02
Trial ID
NCT01409174
Treatments Being Tested
RATIONALE: Vaccines made from a patient's dendritic cells and tumor cells m...
Status
Completed
Location
Norris Cotton Cancer Center at Dartmouth - Hitchcock Medical Center
Start Date
2003-12
Trial ID
NCT00085436
Treatments Being Tested
Pegylated interferon α-2a(Peg-IFN-α) not only inhibit viral replication, bu...
Status
Unknown
Location
Beijing Ditan hospital,Capital Medical University
Start Date
2016-01
Trial ID
NCT03210506
Treatments Being Tested
The primary objective of the study is to estimate the annualized relapse ra...
Status
Terminated
Location
Research Site
Start Date
2015-05
Trial ID
NCT02323269
Treatments Being Tested
Patients with malignant melanoma who had undergone surgery will receive adj...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00723710
Treatments Being Tested
This is a dose-seeking and efficacy study of combined BRAF Inhibitor Vemura...
Status
Completed
Location
Hillman Cancer Center
Start Date
2013-10
Trial ID
NCT01943422
Treatments Being Tested
This study has been designed to evaluate whether "anti-angiogenesis" therap...
Status
Completed
Location
University of Arkansas for Medical Sciences/MIRT
Start Date
1998-08
Trial ID
NCT00083551
RATIONALE: PEG-interferon alfa-2b may interfere with the growth of cancer c...
Status
Terminated
Location
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Start Date
2008-09
Trial ID
NCT00724061
Treatments Being Tested
Tacrolimus is a standard and widely used maintenance immunosuppressive agen...
Status
Completed
Location
The Hospital for Sick Children
Start Date
2011-09
Trial ID
NCT01655563
Treatments Being Tested